by Biotage
HPLC Column for Separation of Synthetic Peptides
Purifying peptides from crude synthetic mixtures can be extremely challenging. The peptides often need to be separated from side products, (deletion and truncated sequences generated during the synthesis) some of which may possess nearly identical sequences. Biotage has a long history in traditional chromatographic separation. Biotage now offers Resolux reversed-phase HPLC columns as an ideal solution for separation of synthetic peptides. The Resolux HPLC columns provide excellent resolution and are an economical choice for the peptide chemist.
| Vendor | Biotage | Internal Diameter | |
| Brand | Resolux 200 C4 | Pore size | 200 |
| Modifification | Silica/C4 | Surface Area | 200 |
| Mode | Reversed-Phase | Carbon Load, % | 4.5 |
| Particle Size | Endcapped | Yes | |
| Length |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| LabHut | Cronusil-L C4 | Reversed-Phase | Silica/C4 | 4.6 mm | 250 mm | 5.0 μm | 300 Å | 287.04 |
| ACE | ACE C4 | Reversed-Phase | Silica/C4 | 10.0 mm | 100 mm | 5.0 μm | 100 Å | On request |
| Dikma Technologies Inc. | Bio-Bond C4 | Reversed-Phase | Silica/C4 | 4.6 mm | 150 mm | 3.0 μm | 300 Å | 592.00 |
| Princeton Chromatography Inc. | PrincetonSPHER C4-300 | Reversed-Phase | Silica/C4 | 30.0 mm | 250 mm | 10.0 μm | 300 Å | On request |
| WATERS | Symmetry 300 C4 | Reversed-Phase | Silica/C4 | 2.1 mm | 50 mm | 3.5 μm | 300 Å | On request |
| LabHut | Cronusil-L C4 | Reversed-Phase | Silica/C4 | 4.0 mm | 150 mm | 5.0 μm | 120 Å | 206.57 |
| Sepax Technologies | Sepax GP 120 C4 | Reversed-Phase | Silica/C4 | 10.0 mm | 250 mm | 10.0 μm | 120 Å | On request |
| Princeton Chromatography Inc. | PrincetonSPHER C4-60 | Reversed-Phase | Silica/C4 | 7.8 mm | 250 mm | 10.0 μm | 60 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
